Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (351524)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: May 7, 2024

Later deadlines: Jun 5, 2024, Jul 5, 2024, Sep 7, 2024, Oct 5, 2024, Nov 5, 2024, Jan 7, 2025, Feb 5, 2025, Mar 5, 2025, May 7, 2025, Jun 5, 2025, Jul 5, 2025, Sep 7, 2025, Oct 5, 2025, Nov 5, 2025, Jan 7, 2026, Feb 5, 2026, Mar 5, 2026, May 7, 2026, Jun 5, 2026, Jul 5, 2026, Sep 7, 2026, Oct 5, 2026, Nov 5, 2026, Jan 7, 2027

Grant amount: Unspecified amount

Fields of work: Cancer/Oncology

Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm local time of applicant organization. Optional but encouraged Letters of Intent are due 30 days prior to a Full Proposal submission.
  • February 5, 2024
  • June 5, 2024
  • October 5, 2024
  • February 5, 2025
  • June 5, 2025
  • October 5, 2025
  • February 5, 2026
  • June 5, 2026
  • October 5, 2026
The following deadlines apply to Renewal/Resubmission/Revision grant applications (due by 5:00 pm local time of applicant organization). Optional but encouraged Letters of Intent are due 30 days prior to a Full Proposal submission.
  • March 5, 2024
  • July 5, 2024
  • November 5, 2024
  • March 5, 2025
  • July 5 , 2025
  • November 5, 2025
  • March 5, 2026
  • July 5, 2026
  •  November 5, 2026
The following deadlines apply to AIDS-related grant applications (due by 5:00 pm local time of applicant organization). Optional but encouraged Letters of Intent are due 30 days prior to a Full Proposal submission.
  • May 7, 2024
  • September 7, 2024
  • January 7, 2025
  • May 7, 2025
  • September 7, 2025
  • January 7, 2026
  • May 7, 2026
  • September 7, 2026
  • January 7, 2027
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This NOFO does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Don't miss out on other good fit funders!

Get personalized grant recommendations, tracking and more by creating a free 14-day account.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed December 19, 2023 and last updated December 19, 2023